Hanish Arnold C's Form 4/A amendment
AmendedDecoy Therapeutics Inc. (DCOY) · filed Jun 6, 2022
- Accession no.
- 0001615219-22-000091
- Filed
- Jun 6, 2022
- Trade date
- Feb 11, 2020
- Filing delay
- 846 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Feb 12, 2020
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $5.00K. It was filed 846 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hanish Arnold CCIK 0001233253 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2020 | Common Stock | PPurchaseAcquired | +4,350 | $1.15 | +$5,002.5 | 7,350 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.